Inventor · disambiguated record
Kamel Mabrouk
Also filed as: MABROUK KAMEL
8 granted patents·4 pending applications·34 citations·filing 1994–2022
80Inventor score
Top patents by PatentIndex Score
12 records- 0168US7829666B2Maurotoxin, PI1 and HSTX1 derivativesCELLPEP PHARMA INC·Filed 2008·Granted Nov 9, 2010·1 cites·14 claims
- 0264US9028818B2Antibodies binding to adrenomedullin receptors and uses thereof as drugsOUAFIK L HOUCINE·Filed 2009·Granted May 12, 2015·2 cites·15 claims
- 0360US5622933AMultiple branch peptide constructions for use against HIVARMEL SA·Filed 1994·Granted Apr 22, 1997·23 cites·27 claims
- 0448US2025051403A1Antimicrobial peptides, variants and chemical analogues thereof and their usesUNIV LILLE·Filed 2022·Application pending·0 cites
- 0545US7285621B2Multiple branch peptide constructionAMBRILIA BIOPHARMA·Filed 2002·Granted Oct 23, 2007·0 cites·15 claims
- 0643US2006229433A1Modified antiviral peptides with increased activity and cell membrane affinityCELLPEP SA·Filed 2004·Application pending·0 cites
- 0742US2004039167A1Maurotoxin, pi1 and hstx1 derivativesFiled 2001·Application pending·0 cites
- 0840US7319089B2Maurocalcine, analogues thereof and their therapeutical usesCELLPEP PHARMA INC·Filed 2001·Granted Jan 15, 2008·0 cites·1 claims
- 0938US2014308298A1Diagnostic and Treatment of an Androgen-Independent Prostate CancerUNIV AIX MARSEILLE·Filed 2012·Application pending·0 cites
- 1037US6379679B1Multiple branch peptide constructionCELLPEP SA·Filed 1999·Granted Apr 30, 2002·8 cites·19 claims
- 1134US10064814B2Use of spider venoms for skin whitening/depigmenting and composition comprising spider venoms molecules or synthetic analogsLABORATOIRE INOYA·Filed 2013·Granted Sep 4, 2018·0 cites·1 claims
- 1224US9474794B2Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugsMABROUK KAMEL·Filed 2011·Granted Oct 25, 2016·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Kamel Mabrouk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →